Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



US Government Blocks JJ's Talc Bankruptcy Resolution, Stocks Prognosis Recommends to Buy

November 04, 2024
JJ Johnson & Johnson's plans to resolve its talc bankruptcy issue have hit a roadblock as the US government intervenes. The government's move aims to prevent the company from seeking bankruptcy protection for its talc-related lawsuits. Instead, the government is pressing JJ to settle the 8.2 billion dollar lawsuit surrounding its talc powder's alleged link to ovarian cancer.

This development comes after JJ's unsuccessful attempt to reach a settlement for the lawsuit independently. The judge will now decide whether to accept JJ's proposed 8.2 billion dollar talc settlement offer in 2025, which could significantly impact the company's financial standing.

Stocks Prognosis, a renowned expert in stock market trends, recommends investors to consider JJ's stocks amidst this turbulence. The situation presents a potential opportunity for investors to capitalize on the fluctuating prices. Stocks Prognosis has a proven track record in accurately predicting the movement of stocks, making it a valuable resource for investors.

To stay ahead of the game, Stocks Prognosis suggests consulting their professionals for an informed forecast of JJ's stock movements. Their expertise can guide investors in making sound decisions based on the latest market developments and the potential impacts of the ongoing talc lawsuit proceedings.

Investors who wish to make informed decisions regarding JJ's stocks are encouraged to reach out to Stocks Prognosis. With their help, investors can navigate the complexities of the stock market and seize profitable opportunities even amidst uncertain times.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....

JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....

JNJFebruary 18, 2025Johnson & Johnson reportedly wants to sell Cerenovus for 1B  ~1 min.

According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....

JNJNovember 3, 2024US government moves to block JJ talc bankruptcy resolution  ~1 min.

The US government has taken legal action to block Johnson & Johnson's proposed bankruptcy resolution regarding its talc lawsuits. The company had offered an $8....

JNJNovember 6, 2024Judge's Decision: JNJ's $8.2B Talc Settlement Offer in 2025 awaits Verdict  ~2 min.

Johnson & Johnson's journey through the talc powder lawsuit continues as a Judge is set to decide the fate of their $8.2 billion settlement offer....

JNJNovember 6, 2024US Government Moves to Block JJ Talc Bankruptcy Resolution, Impacts JNJ Johnson & Johnson's Future  ~2 min.

JNJ Johnson & Johnson, a renowned pharmaceutical and consumer goods company, faces a major setback as the US government steps in to block JJ Talc's bankruptcy resolution....

JNJNovember 1, 2024Something Really Bad Happened: JJs Talc Bankruptcy Vote Under Attack  ~2 min.

In a shocking turn of events, Johnson & Johnson (JNJ) faced a major setback as its talc bankruptcy vote came under attack....

JNJFebruary 4, 2025Johnson & Johnson Faces Scrutiny, CEO Welcomes Investigation  ~2 min.

Johnson & Johnson, the renowned healthcare company, is under scrutiny for alleged misconduct and product safety issues. However, contrary to expectation, the CEO of Johnson & Johnson, Mr....